Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
GMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$49.33 - $94.93
Previous CloseN/A
Volume442.39K
Average Volume (3M)1.28M
Market Cap
$11.55B
Enterprise Value$9.72B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)126.9
Beta0.97
Next Earnings
Feb 20, 2025EPS Estimate
0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.66
Shares Outstanding113,737,240
10 Day Avg. Volume1,334,020
30 Day Avg. Volume1,277,569
Standard Deviation0.10
R-Squared0.37
Alpha0.00052
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.66
Price to Cash Flow (P/CF)14.20
P/FCF Ratio17.80
Enterprise Value/Market Cap0.84
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit9.53
Enterprise Value/Ebitda18.78
Forecast
1Y Price Target
$99.00Price Target Upside17.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe acquisition of Nevro is seen as a strategically sound move that expands Globus Medical's offerings in the SI-joint fusion space and the neuromodulation market.
Earnings GrowthThe acquisition is expected to be accretive to earnings in the second year of operation, indicating potential financial benefits for Globus Medical.
Financial PerformanceThe deal offers a very attractive valuation from Globus Medical's perspective, implying a favorable financial transaction.
Bears Say
Acquisition RisksAdding another large-scale project like the Nevro acquisition could prove to be a distraction for Globus Medical.
Financial DrawbacksThe merger model shows the deal is dilutive in the initial years, indicating potential short-term financial drawbacks.
Market SkepticismInvestors may be skeptical of the SCS market and NVRO due to its challenging nature and potential to dilute GMED's growth.
---
Ownership Overview
16.45% Insiders
30.69% Mutual Funds
0.69% Other Institutional Investors
31.09% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $49.33 and its highest was $94.93 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $11.55B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Feb 20, 2025 which is yesterday.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Feb 20, 2025. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.748 by $0.092.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 0.75.
How many shares outstanding does Globus Medical have?
Globus Medical has 113,737,240 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.84 in its last earnings report, beating expectations of $0.748. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Globus Medical?
Currently, no hedge funds are holding shares in GMED
---
Globus Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$99.00 (17.69% Upside)
$99.00 (17.69% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 28.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.24%
12-Months-Change
Fundamentals
Return on Equity
2.22%
Trailing 12-Months
Asset Growth
-5.04%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
---
GMED Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Globus Medical's earnings call highlighted strong sales growth and successful product launches, along with record free cash flow and an increase in annual guidance. However, challenges such as the FDA warning letter and a decline in gross profit margins were noted. Overall, the positive aspects of growth and innovation outweigh the concerns.Read More>---
GMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
---
GMED Stock 12 Month Forecast
Average Price Target
$99.00
▲(17.69% Upside)
Technical Analysis
Baxter International
―
Integra Lifesciences
―
Smith & Nephew Snats
―
Zimmer Biomet Holdings
―
Medpace Holdings
―
Best Analysts Covering GMED
1 Year
1 Year Success Rate
24/31 ratings generated profit
1 Year Average Return
+20.42%
reiterated a buy rating 12 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 77.42% of your transactions generating a profit, with an average return of +20.42% per trade.
---